Form 4 for SRPT Sarepta Therapeutics, Inc.
Accepted 2021-12-14 00:00:00 ET · period of report 2021-12-10 · accession 0001209191-21-069638 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-12-14 | 2021-12-10 | SRPT | GRAY MARY ANN | Dir | M - OptEx | $0.00 | +967 | 9,403 | +11% | $0 |
| D | 2021-12-14 | 2021-12-10 | SRPT | GRAY MARY ANN | Dir | M - OptEx | $0.00 | -967 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-10 | M | A | 967 | $0.00 | 9,403 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of Sarepta Therapeutics, Inc. common stock. |
| 2 | Derivative | Restricted Stock Units | 2021-12-10 | M | D | 967 | $0.00 | 0 | D | — · 2021-12-10 to — | 967 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of Sarepta Therapeutics, Inc. common stock. (F2) The third out of three annual equal installments of restricted stock units vested on December 10, 2021. |